{
    "code": "02020549",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020549",
    "time": "2019-09-20 03:28:17",
    "許可證字號": "衛署藥輸字第020549號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/07\/22",
    "發證日期": "83\/07\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202054903",
    "中文品名": "鈣而可５０單位注射液",
    "英文品名": "CALCO INJECTION 50 I.U.",
    "適應症": "高血鈣危象、骨骼的帕哲特氏病(僅適合對替代療法無效或不適合這類療法的病人，如腎功能嚴重受損者)。",
    "劑型": "270注射劑",
    "包裝": "安瓿 盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "CALCITONIN SALMON",
    "主製造廠": {
        "申請商名稱": "0807901100  和聯生技藥業股份有限公司",
        "申請商地址": "台北市敦化北路３１１號５樓",
        "主製造廠": "",
        "製造廠名稱": "FIT0181000  LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA S.P.A"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6836000110",
            "成分名稱": "CALCITONIN SALMON",
            "含量描述": "50",
            "含量": "50.0000000000",
            "單位": "IU (I"
        }
    ],
    "仿單外盒": [
        {
            "title": "鈣而可50單位注射液_衛署藥輸字第020549號_中文仿單-102-12-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020549&Seq=001&Type=9"
        },
        {
            "title": "020205490002-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020549&Seq=001&Type=8"
        }
    ]
}